Efferent Labs' Convertible Note Round

Efferent Labs raised a round of funding on December 31, 2015.

Efferent Labs, formerly Raland Therapeutics, is a preclinical stage medical technology company focused on implantable biosensors. The company's CytoComm Biosensor Platform is designed to serve as a re…

Articles about Efferent Labs' Convertible Note Round: